Cleveland Biolabs Inc., of Buffalo, N.Y., said it entered a securities purchase agreement with Mikhail Mogutov, chairman of the board of Incuron LLC and one institutional investor, for a private placement of $3.5 million worth of the company's common stock, par value $0.005 per share and warrants to purchase common stock.